Login / Signup

Lipid-Based Nanomedicine for Alzheimer's Disease: A Comprehensive Review of Recent Advances.

Sanchit DhankharNitika GargHimanshu SharmaSamrat ChauhanMonika Saini
Published in: Pharmaceutical nanotechnology (2024)
Nano Lipid Carriers (NLCs) are recognized for their ability to target the brain effectively due to their lipid-loving properties and compatibility with living tissues. They improve the absorption of drugs in the brain while decreasing the accumulation of drugs in unintended organs. This work emphasises the importance of nano lipid carriers, which are lipophilic and biocompatible and have demonstrated exceptional targeting efficiency, making them an ideal carrier system for delivering medications to the brain.
Keyphrases
  • resting state
  • white matter
  • fatty acid
  • functional connectivity
  • cerebral ischemia
  • cancer therapy
  • gene expression
  • cognitive decline
  • drug delivery
  • drug release
  • drug induced